Mace

(redirected from Major Adverse Cardiac Events)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

Mace

A unit of weight in Taiwan approximately equivalent to 3.75 grams. It is used primarily in the sale of bulk foodstuffs.
References in periodicals archive ?
Iroko Cardio aims to contribute to the reduction of Major Adverse Cardiac Events in the regions it serves.
An observed 74 percent reduction in major adverse cardiac events (MACE) compared to TAXUS at nine months (3.
It is rare in cardiology to find that a new technology not only prevents major adverse cardiac events such as heart attacks and saves lives, but also substantially saves resources," said Professor Uwe Siebert, M.
Resverlogix's clinical dataset, consisting of patients treated with the first BET inhibitor to be tested in the clinic, provides an unprecedented opportunity to examine factors contributing to drug efficacy, major adverse cardiac events and safety for this drug class.
In total, 87 major adverse cardiac events occurred among the patients during the follow-up period.
This study showed no new major adverse cardiac events (MACE) were reported since the one-year analysis, and the incidence of late stent thrombosis for patients treated with Custom NX was zero percent.
But because of the increased rate of death and MI in the sirolimus-eluting stent group, the early advantage in this group in the overall rate of major adverse cardiac events eventually disappeared.
The trial primary endpoint is Major Adverse Cardiac Events at 12 months post-procedure.
The authors reported that subgroup analysis of the primary endpoint of 9-month Major Adverse Cardiac Events (MACE, defined as a composite of cardiac death, myocardial infarction [MI], or target vessel revascularization [TVR]) were also consistent across all subgroups.
Subsequent to SPIRIT III meeting its primary and major secondary endpoints, an analysis of nine-month Major Adverse Cardiac Events (MACE), such as cardiac death, heart attack or target lesion revascularization (artery re-treatment due to lack of blood supply), was undertaken in which XIENCE V demonstrated superiority to TAXUS with a statistically significant 44 percent reduction in MACE at nine months compared to TAXUS (4.
For such patients, the committee recommended transmyocardial revascularization to provide sustained angina relief, reduce major adverse cardiac events, and improve exercise performance, on the basis of results of randomized, controlled trials (level A evidence); and to reduce readmissions and reinterventions, on the basis of one randomized, controlled trial and nonrandomized data (level B evidence).
Acronym definitions: LVEF = left ventricular ejection fraction, CABG= coronary artery bypass graph or heart surgery, IAB = intra-aortic balloon, MACE = major adverse cardiac events, ICD = implantable cardiac defibrillator
Full browser ?